Holland & Barrett's pre-tax profits rise to €2.97m as online sales and expansion fuel revenue increase

Holland & Barrett has been expanding here in recent years, and it opened two new stores last year following seven new store openings in the prior year. It closed one store last year which followed two store closures in 2024.

Pre-tax profits at the largest health food retailer in Ireland, Holland & Barrett, last year increased by 12% to €2.97m.

New accounts filed by Holland & Barrett Ltd show that revenues increased by 12.5% from €66.36m to €74.74m in the 12 months to the end of September last year.

The revenue increase — boosted by a surge in online revenues — followed the number of outlets on the island of Ireland increasing from 68 to 69 last year. Numbers employed increased from 417 to 426 as staff costs rose from €11.39m to €12.6m.

The directors said “both the level of business and the year-end financial position are in line with expectations”.

The business has been expanding here in recent years, and it opened two new stores last year following seven new store openings in the prior year. It closed one store last year which followed two store closures in 2024.

The firm did not pay out a dividend last year after paying out a dividend of €59.13m for 2024. The company recorded a post-tax profit of €2.56m after incurring a corporation tax charge of €405,000.

In their report, the directors said the management of the business continues to monitor the cost base closely. A note attached to the accounts states that the group meets its day-to-day working capital requirements through its operational performance.

They said: “However, throughout the period to 30 September 2026, the group is continuing to undertake significant investment to transform the business to achieve the strategy.”

A breakdown of revenues shows that €54.83m was generated by retail sales, with €7.2m recorded by franchise and wholesale income, while online sales rose from €9.97m to €12.59m.

The profit takes account of non-cash depreciation costs of €1.57m and a €547,000 write-down in stocks. The profit also takes account of €5.9m in operating lease costs.

At the end of September 2025, the company had accumulated profits of €14.79m. The company’s cash funds almost doubled from €2.94m to €5.2m. 

Holland & Barrett International

Globally, Holland & Barrett International recorded a pre-tax loss of £71m in the 12 months to the end of September 2025 as revenues increased by 11% to £981m. The loss takes account of combined non-cash depreciation and amortisation charges of £138m.

In his report, CEO of the global business, Anthony Houghton, said over the past year Holland & Barrett has delivered strong progress across all our markets, from the UK & Ireland to the Benelux Region, China and the Middle East.

He said: “Our performance reflects both disciplined execution and the millions of everyday moments where we help customers make better decisions about their health."